These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 36315051)

  • 21. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
    van Rixel VH; Busemann A; Göttle AJ; Bonnet S
    J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors.
    Zhang L; Wang P; Zhou XQ; Bretin L; Zeng X; Husiev Y; Polanco EA; Zhao G; Wijaya LS; Biver T; Le Dévédec SE; Sun W; Bonnet S
    J Am Chem Soc; 2023 Jul; 145(27):14963-14980. PubMed ID: 37379365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in ruthenium anticancer drugs.
    Levina A; Mitra A; Lay PA
    Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lightening up Ruthenium Complexes to Fight Cancer?
    Mari C; Gasser G
    Chimia (Aarau); 2015; 69(4):176-81. PubMed ID: 26668934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Arene Ruthenium Antitumor Complexes.
    Su W; Tang Z; Li P
    Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent
    van Geest EP; Götzfried SK; Klein DM; Salitra N; Popal S; Husiev Y; Van der Griend CJ; Zhou X; Siegler MA; Schneider GF; Bonnet S
    Photochem Photobiol; 2023 Mar; 99(2):777-786. PubMed ID: 36315051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruthenium-Based Photoactivated Chemotherapy.
    Bonnet S
    J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
    Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
    Papish ET; Oladipupo OE
    Curr Opin Chem Biol; 2022 Jun; 68():102143. PubMed ID: 35483128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
    Pal M; Nandi U; Mukherjee D
    Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.